Inhibitory effect of ligustrazine on proliferation of rabbit vascular smooth muscle cells after arterial injury

Acta Pharmacologica Sinica

Volumn 20, Issue 10, 1999, Pages 917-922

  Li, Song ^a   Wang, Jian Hua ^b   Chen, Sheng Lan ^c  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c Guanghou Inst Obstet/Gynecology   (China)

Author keywords

Balloon dilatation; Cell division; Cultured cells; Ligustrazine; Thoracic aorta; Vascular smooth muscle

Indexed keywords

TETRAMETHYLPYRAZINE; THYMIDINE; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INJURY; ARTICLE; BALLOON DILATATION; CELL PROLIFERATION; CONTROLLED STUDY; MALE; MUSCLE CELL; NONHUMAN; RABBIT; THORACIC AORTA; VASCULAR SMOOTH MUSCLE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; AORTA; CELL DIVISION; CELLS, CULTURED; MALE; MUSCLE, SMOOTH, VASCULAR; PYRAZINES; RABBITS; RANDOM ALLOCATION; THYMIDINE; VASODILATOR AGENTS;

EID: 0032705193     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Landzberg BR, Frishman WH, Lerrick K. Pathophysiology and pharmacological approaches for prevention of coronary artery restenosis following coronary artery balloon angioplasty and related procedures. Prog Cardiovasc Dis 1997; 39: 361-98.
2. Lefkovits J, Topol EJ. Pharmacological approaches for the prevention of restenosis after percutaneous coronary intervention. Prog Cardiovasc Dis 1997; 40: 141-58.
3. Sluiter W, de Vree WJ, Pietersma A, Koster JF. Prevention of late lumen loss after coronary angioplasty by photodynamic therapy: role of activated neutrophils. Mol Cell Biochem 1996; 157: 233-8.
4. Kwan CY, Daniel EE, Chen MC. Inhibition of vasoconstriction by tetramethylpyrazine; does it act by blocking the voltage-dependent Ca channel? J Cardiovasc Pharmacol 1990; 15: 157-62.
5. Peng W, Hucks D, Priest RM, Kan YM, Ward JP. Ligustrazine-induced endothelium-dependent relaxation in pulmonary arteries via an NO-mediated and exogenous L-arginine-dependent mechanism. Br J Pharmacol 1996; 119: 1063-71.
6. Sutter MC, Wang YX. Recent cardiovascular drugs from Chinese medicinal plants. Cardiovasc Res 1993; 27: 1891-901.
7. Tang LL, Wang LH, Zhu GY, Zhang JH. Influence of ligustrazine and heparin on growth and cleavage of primary cultural vascular smooth muscle (Chinese). Chin J Integ Trad West Med 1995; 15: 38-9.
8. Wu WK, Xie QJ, Hou C, He Q, Li S. Effects of xiao shuan oral preparations on aortic wall by balloon dilation lesion in rabbits. Chin J Arterioscler 1996; 4: 268-71.
9. Liu MW, Roubin GS, King SB III. Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia. Circulation 1989; 79: 1374-87.
10. Doomekamp FN, Borst C, Post MJ. Endothelial cell recoverage and intimal hyperplasia after endothelium removal with or without smooth muscle cell necrosis in the rabbit carotid artery. J Vase Res 1996; 33: 146-5.
11. Tang LL, Wang LH, Zhang JH. Effect of tetramethylpyrazine on expression of collagen genes in primary cultured smooth muscle cells in rats (Chinese). Chin J Integ Trad West Med 1995; 15: 666-8.
12. Amagaya S, Harada K, Miyake A, Iwama H, Ogihara Y. A new pharmacological testing method-Different effects of levamisole and the serum of mice orally treated with levamisole on mitogenic activity of lipopolysaccharide. Chem Pharm Bull (Tokyo) 1989; 37: 1117-9.
13. Vermylen J. Clinical trials of primary and secondary prevention of thrombosis and restenosis. Thromb Haemost 1995; 74: 377-81.
14. Brogden RN, Benfield P. Verapamil: a review of its pharmacological properties and therapeutic use in coronary artery disease. Drugs 1996; 51: 792-819.